OSE Immunotherapeutics
OSE.PA
5,15 €
Share price
0.59%
Change (1 day)
-21.69%
Change (1 year)
Categories
OSE Immunotherapeutics (OSE.PA) - P/B ratio
P/B ratio as of July 2025 : 2.07
According to OSE Immunotherapeutics's latest financial reports the company has a price-to-book ratio of 1.89449.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
OSE Immunotherapeutics - P/B ratio (from 2015 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 2.50 | -37.75% |
| 2023-12-31 | 4.02 | 6.65% |
| 2022-12-31 | 3.77 | -5.04% |
| 2021-12-31 | 3.97 | 88.52% |
| 2020-12-31 | 2.11 | 122.8% |
| 2019-12-31 | 0.9453 | 16.27% |
| 2018-12-31 | 0.8130 | -18.35% |
| 2017-12-31 | 0.9958 | -36.17% |
| 2016-12-31 | 1.56 | -73.38% |
| 2015-12-31 | 5.86 | |
| 2014-12-31 | N/A | |
| 2013-12-31 | N/A |